首页> 外文期刊>The Egyptian Rheumatologist >Potential role of high sensitivity cardiac troponin T in subclinical coronary atherosclerosis in systemic lupus erythematosus patients
【24h】

Potential role of high sensitivity cardiac troponin T in subclinical coronary atherosclerosis in systemic lupus erythematosus patients

机译:高灵敏度心肌肌钙蛋白T在全身性狼疮性红斑患者亚临床冠状动脉粥样硬化中的潜在作用

获取原文
           

摘要

Aim of the workTo determine the role of high sensitivity cardiac troponin T (HS cTnT) in subclinical coronary atherosclerosis in SLE patients at an apparent low risk for CVD according to traditional risk factors.Patients and methodsThe presence of subclinical coronary atherosclerosis was assessed by non-contract coronary computerized tomography and calcium score was measured using Agatston score in 30 SLE patients asymptomatic for CVD and 30 age and sex matched apparently healthy controls. SLE disease activity index (SLEDAI) was assessed. Serum HScTnT concentration was measured using enzyme-linked immunosorbent assay (ELISA).ResultsThe mean age of the patients was 33?±?5.7?years, disease duration of 33.7?±?22?months and mean SLEDAI 8.1?±?5.02. The mean HS cTnT level was 12.8?±?11.3?ng/L (1–36?ng/L). Their Framingham score was 4.8?±?3.1 (1–12). Framingham score was low in both SLE patients (range 1–12%) and controls (1–9%) (p?=?0.12). 11 (36.7%) patients, but none of the controls, had coronary artery calcification (CAC). Serum HScTnT concentration was detectable (>3 ng/L) in 16 (53.3%) patients and 2 (6.7%) control (p?
机译:根据传统风险因素,确定高敏感性心肌肌钙蛋白T(HS CTNT)在SLE患者中表现低风险的高敏感性心肌肌钙蛋白T(HS CTNT)的作用。通过非 - 潜水冠状动脉粥样硬化的存在和方法。合同冠状动脉电脑层析成像和钙分数使用agatston评分在30岁的SLE患者中令人遗憾的是CVD和30岁和性别匹配明显健康的对照。 SLE疾病活动指数(SLEDAI)被评估。使用酶联免疫吸附测定(ELISA)测量血清HSCTNT浓度平均HS CTNT水平为12.8?±11.3?Ng / L(1-36?ng / L)。他们的框架得分为4.8?±3.1(1-12)。 SLAM患者(1-12%)和对照(1-9%)(P?= 0.12),Framingham评分低。 11(36.7%)患者,但没有任何对照,具有冠状动脉钙化(CAC)。血清HSCTNT浓度在16例(53.3%)患者中可检测到(> 3 ng / L),2(6.7%)对照(p≤0.001)。有趣的是,它在所有CAC的患者中可检测到,但只有26.3%的患者没有(P?<0.001)。 HSCTNT与agatston显着相关(r?= 0.63,p?= 0.04),红细胞沉降速率(R?= 0.65,p≤0.03),以及C-反应蛋白(R?= 0.76在SLE患者中,p?= 0.03),CaC.conclusionserum HSCTNT水平高,与CAC相关的SLE患者,根据Framingham风险评分对CVD的风险显然低。 HS CTNT可以是SLE相关的亚临床动脉粥样硬化的有用生物标志物。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号